Abiopharma

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

CoyaTherapeutics - Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting

Cushman & Wakefield Report Highlights Strong Growth and Tight Supply in U.S. Medical Outpatient Building Sector

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Letter to Shareholders from Conn Davis, Chief Executive Officer: First 100 Days

Premier Air Charter Discusses FAA Approval, Growth Strategy, and Market Trends in Follow-Up Interview

Allegro MicroSystems Appoints Brian White to its Board of Directors

BGC Group Launches Compute Infrastructure Markets

Enphase Energy Begins Shipments of GaN-Based 548 VA IQ9S Commercial Microinverters in the United States

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease